Correction to “HLA-B Associates With Distinct Disease Expression in Juvenile Spondyloarthritis: A Retrospective Cohort Study” - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Erratum for “HLA-B Correlates With Unique Disease Manifestations in Juvenile Spondyloarthritis: A Retrospective Cohort Analysis”

  • September 15, 2026

Share

  • 1

    An erratum was issued for the article on HLA-B and juvenile spondyloarthritis published in ACR Open Rheumatology.

  • 2

    The erratum addresses a typesetting error found in Table 2 of the Results section.

  • 3

    The error involved an incorrect assignment of superscript 'c' in the table.

  • 4

    The superscript 'c' should be deleted from the value for B*18:01 and IBD-AA.

  • 5

    The correct assignment of superscript 'c' is to be made for B*35:02 and IBD-AA.

Original Source(s)

Correction to “HLA-B Associates With Distinct Disease Expression in Juvenile Spondyloarthritis: A Retrospective Cohort Study”

  • September 15, 2026

Related Content

Correction: Electroacupuncture delays the progression of juvenile collagen-induced arthritis via regulation NLRP3/NF-κB signaling pathway -mediated pyroptosis and its influence on autophagy

Can an antibody aid neuropsychiatric SLE diagnosis?

Investigators compared a candidate biomarker across three diagnostic groups.

FDA approves first therapy for warm autoimmune hemolytic anemia

The phase 2/3 ENERGY trial evaluated durable hemoglobin response with nipocalimab vs placebo in adults with warm autoimmune hemolytic anemia.